Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - OtherRevenue - Other
Ratios

Bolt Biotherapeutics (BOLT) Preferred Shares Issued (2020 - 2021)

Bolt Biotherapeutics (BOLT) has disclosed Preferred Shares Issued for 2 consecutive years, with $51.9 million as the latest value for Q1 2021.

  • Quarterly Preferred Shares Issued changed N/A to $51.9 million in Q1 2021 from the year-ago period, while the trailing twelve-month figure was $51.9 million through Dec 2021, changed N/A year-over-year, with the annual reading at $51.9 million for FY2021, 25.76% up from the prior year.
  • Preferred Shares Issued hit $51.9 million in Q1 2021 for Bolt Biotherapeutics, up from -$276000.0 in the prior quarter.
  • In the past five years, Preferred Shares Issued ranged from a high of $51.9 million in Q1 2021 to a low of -$276000.0 in Q3 2020.